A changing paradigm of treatment of kidney transplant recipients is a new, wider approach to immunosuppression, which should take into account both antiviral and anticancer effects, in addition to cardiovascular protection. Recent observations suggest that the early introduction of mammalian target of rapamycin inhibitors (mTORi) in association with low dose CNI may offer many of these effects. The present manuscript summarizes benefits and contraindications of combinations with mTORi in kidney transplant immunosuppressive strategies.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
kidney transplant
8
[mtor inhibitors
4
inhibitors kidney
4
kidney transplantation]
4
transplantation] changing
4
changing paradigm
4
paradigm treatment
4
treatment kidney
4
transplant recipients
4
recipients wider
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!